Center for Cancer Genomics
Accelerating and Applying Our Discoveries
The Center for Cancer Genomics (CCG) is part of the Precision Cancer Medicine effort at Dana-Farber Cancer Institute. CCG's mission is to facilitate the design, execution, and analysis of cancer research projects through collaborations with investigators. We continually develop and adapt new technologies to accelerate discoveries in cancer genomics and apply these discoveries to improve personalized patient care.
Announcements
11th Annual CCG Symposium: Cancer Genomics and Personalized Medicine
March 14, 2025
The Center for Cancer Genomics's annual symposium on Personalized Cancer Medicine will take place on March 14, 2025. The symposium is tailored to anyone interested in personalized cancer medicine and genomics technologies, including clinicians, researchers, fellows, postdocs, and students. This year we are proud to have Dr. Fei Chen, PhD (Broad Institute; Associate Professor, Department of Stem Cell and Regenerative Biology, Harvard University), Dr. Alice Shaw, MD, PhD (Chief, Strategic Partnerships, Dana-Farber Cancer Institute), and many more distinguished speakers.
Collaborate With Us
The Center for Cancer Genomics continuously evaluates and develops genomic technologies for both research and clinical use. We provide a host of services that include project design, sequencing library construction, custom design and validation of hybrid capture gene panels for targeted sequencing, single-cell/nucleus workflows, bioinformatic analysis, and more.
Contact the Center for Cancer Genomics
CCG Associate Director: Aaron Thorner
DCBC Biopsy Collections: Karla Helvie
Bioinformatics: Tony Anselmo
For general questions:
617-582-7253 or aaron_thorner@dfci.harvard.edu
